Cargando…
1H 2020: 16% revenue growth driven by high demand for Topsoe's market-leading technologies and catalysts; order intake reduced during COVID-19 pandemic
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492050/ http://dx.doi.org/10.1016/j.focat.2020.09.012 |
| _version_ | 1783582309296898048 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7492050 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74920502020-09-16 1H 2020: 16% revenue growth driven by high demand for Topsoe's market-leading technologies and catalysts; order intake reduced during COVID-19 pandemic Focus on Catalysts Article Published by Elsevier Ltd. 2020-10 2020-09-15 /pmc/articles/PMC7492050/ http://dx.doi.org/10.1016/j.focat.2020.09.012 Text en Copyright © 2020 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article 1H 2020: 16% revenue growth driven by high demand for Topsoe's market-leading technologies and catalysts; order intake reduced during COVID-19 pandemic |
| title | 1H 2020: 16% revenue growth driven by high demand for Topsoe's market-leading technologies and catalysts; order intake reduced during COVID-19 pandemic |
| title_full | 1H 2020: 16% revenue growth driven by high demand for Topsoe's market-leading technologies and catalysts; order intake reduced during COVID-19 pandemic |
| title_fullStr | 1H 2020: 16% revenue growth driven by high demand for Topsoe's market-leading technologies and catalysts; order intake reduced during COVID-19 pandemic |
| title_full_unstemmed | 1H 2020: 16% revenue growth driven by high demand for Topsoe's market-leading technologies and catalysts; order intake reduced during COVID-19 pandemic |
| title_short | 1H 2020: 16% revenue growth driven by high demand for Topsoe's market-leading technologies and catalysts; order intake reduced during COVID-19 pandemic |
| title_sort | 1h 2020: 16% revenue growth driven by high demand for topsoe's market-leading technologies and catalysts; order intake reduced during covid-19 pandemic |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492050/ http://dx.doi.org/10.1016/j.focat.2020.09.012 |